Biotrial
Biotrial is a full-service CRO specializing in early clinical development, supporting biotech and small- to mid-sized pharmaceutical companies in the global development of innovative therapies. With two dedicated Phase I units in Europe and the United States, Biotrial conducts studies in both healthy volunteers and patients, offering a total capacity of 260 beds (150 in the US and 100 in France). Biotrial provides end-to-end expertise from First-in-Human (FIH) to Proof-of-Concept (POC), including a broad range of Phase I clinical pharmacology studies. With over 35 years of experience, Biotrial has developed deep expertise across more than 20 therapeutic areas, with strong specialized clinical and core lab capabilities in Cardiology, Oncology, and Neuroscience.
